ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,972 | -22.7% | 366,298 | +9.6% | 0.01% | -10.0% |
| Q2 2023 | $464,631 | +10.7% | 334,267 | +26.6% | 0.01% | +11.1% |
| Q1 2023 | $419,906 | -85.6% | 264,092 | -43.5% | 0.01% | -86.8% |
| Q4 2022 | $2,910,874 | +46.0% | 467,235 | +57.0% | 0.07% | +36.0% |
| Q3 2022 | $1,994,000 | +15.5% | 297,658 | +9.6% | 0.05% | +11.1% |
| Q2 2022 | $1,727,000 | +21.5% | 271,543 | +784.5% | 0.04% | -84.7% |
| Q2 2017 | $1,421,000 | – | 30,700 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |